Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Contrast agents are substances applied in medical imaging to increase visibility of internal structures like organs, blood vessels, and other tissues. Before the imaging operation, they are frequently injected into the body or taken orally to boost contrast and enhance the visibility of specific structures.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Contrast Agents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Contrast Agents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Contrast Agents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Contrast Agents Overview
  • Products under Development
    • Contrast Agents - Pipeline Products by Stage of Development
      • Table Contrast Agents - Pipeline Products by Stage of Development
      • Table Contrast Agents - Pipeline Products by Stage of Development
    • Contrast Agents - Pipeline Products by Segment
      • Table Contrast Agents - Pipeline Products by Segment
      • Table Contrast Agents - Pipeline Products by Segment
    • Contrast Agents - Pipeline Products by Territory
      • Table Contrast Agents - Pipeline Products by Territory
      • Table Contrast Agents - Pipeline Products by Territory
    • Contrast Agents - Pipeline Products by Regulatory Path
      • Table Contrast Agents - Pipeline Products by Regulatory Path
      • Table Contrast Agents - Pipeline Products by Regulatory Path
    • Contrast Agents - Pipeline Products by Estimated Approval Date
      • Table Contrast Agents - Pipeline Products by Estimated Approval Date
      • Table Contrast Agents - Pipeline Products by Estimated Approval Date
    • Contrast Agents - Ongoing Clinical Trials
      • Table Contrast Agents - Ongoing Clinical Trials
      • Table Contrast Agents - Ongoing Clinical Trials
  • Contrast Agents - Pipeline Products under Development by Companies
    • Contrast Agents Companies - Pipeline Products by Stage of Development
      • Table Contrast Agents Companies - Pipeline Products by Stage of Development
    • Contrast Agents - Pipeline Products by Stage of Development
      • Table Contrast Agents - Pipeline Products by Stage of Development
  • Contrast Agents Companies and Product Overview
    • 3B Pharmaceuticals GmbH Company Overview
      • 3B Pharmaceuticals GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3B Pharmaceuticals GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3B 202 - Product Status
        • Table 3B 202 - Product Description
        • Table 3B 222 - Product Status
        • Table 3B 222 - Product Description
        • Table 3B 302 - Product Status
        • Table 3B 302 - Product Description
        • Table 3B 402 - Product Status
        • Table 3B 402 - Product Description
        • Table 3B 502 - Product Status
        • Table 3B 502 - Product Description
        • Table NN - Product Status
        • Table NN - Product Description
    • 5M Biomed LLC Company Overview
      • 5M Biomed LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 5M Biomed LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Molecular Imaging Probe - Product Status
        • Table Molecular Imaging Probe - Product Description
        • Table Surface Functionalized Magnetic Iron Oxide Nanorods - Product Status
        • Table Surface Functionalized Magnetic Iron Oxide Nanorods - Product Description
        • Table Water Soluble Magnetic Iron Oxide Nanocubes - Product Status
        • Table Water Soluble Magnetic Iron Oxide Nanocubes - Product Description
    • Abscint nv Company Overview
      • Abscint nv Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abscint nv Pipeline Products & Ongoing Clinical Trials Overview
        • Table ABSCINT-206 - Product Status
        • Table ABSCINT-206 - Product Description
    • AC Immune SA Company Overview
      • AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table TDP-43-PET Tracer - Product Status
        • Table TDP-43-PET Tracer - Product Description
    • AccuNovo Biotechnologies Inc Company Overview
      • AccuNovo Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AccuNovo Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 64Cu Labeled NTSR1-Targeting PET Agent - Product Status
        • Table 64Cu Labeled NTSR1-Targeting PET Agent - Product Description
    • AdAlta Ltd Company Overview
      • AdAlta Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table AdAlta Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Granzyme B PET Imaging Agent - Product Status
        • Table Granzyme B PET Imaging Agent - Product Description
    • Adamas Nanotechnologies Inc Company Overview
      • Adamas Nanotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adamas Nanotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Photo-Hyperpolarizable Nanodiamond-Based 13C Contrast Agent - Product Status
        • Table Photo-Hyperpolarizable Nanodiamond-Based 13C Contrast Agent - Product Description
    • Adiposs SA Company Overview
      • Adiposs SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adiposs SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ImageBAT - Product Status
        • Table ImageBAT - Product Description
    • Aestas Pharma Inc Company Overview
      • Aestas Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aestas Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AP-251 - Product Status
        • Table AP-251 - Product Description
    • Affibody AB Company Overview
      • Affibody AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Affibody AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table GE-226 - Product Status
        • Table GE-226 - Product Description
    • Akrotome Imaging Inc Company Overview
      • Akrotome Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Akrotome Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FIRE Probe - Breast Cancer - Product Status
        • Table FIRE Probe - Breast Cancer - Product Description
    • Alume Biosciences Inc Company Overview
      • Alume Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alume Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ALM-488 - Product Status
        • Table ALM-488 - Product Description
        • Table Alume Biosciences Inc - Ongoing Clinical Trials Overview
        • Table ALM-488 - ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery
    • Alzeca Biosciences Inc Company Overview
      • Alzeca Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alzeca Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ADx Nanoparticle - Product Status
        • Table ADx Nanoparticle - Product Description
        • Table Alzeca Biosciences Inc - Ongoing Clinical Trials Overview
        • Table ADx Nanoparticle - A Phase 1, Controlled, Open-label, Single Dose, Dose-escalation, Clinical Proof-of-concept Study of MRI Enhanced With ADx-001 (DSPE-DOTA-Gd Liposomal Injection) in Patients with Brain Amyloid Deposits as Demonstrated by Amyloid PET
    • Amydis Inc Company Overview
      • Amydis Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amydis Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AMDX-201 - Product Status
        • Table AMDX-201 - Product Description
        • Table AMDX-2011P - Product Status
        • Table AMDX-2011P - Product Description
        • Table Diagnostic Probe - Creutzfeldt-Jakob Disease - Product Status
        • Table Diagnostic Probe - Creutzfeldt-Jakob Disease - Product Description
        • Table Fluorescent Retinal Contrast Agent - Parkinson's Disease - Product Status
        • Table Fluorescent Retinal Contrast Agent - Parkinson's Disease - Product Description
        • Table Fluorescent Retinal Tracer - Product Status
        • Table Fluorescent Retinal Tracer - Product Description
        • Table TDP-43 Retinal Tracer - Product Status
        • Table TDP-43 Retinal Tracer - Product Description
        • Table Amydis Inc - Ongoing Clinical Trials Overview
        • Table AMDX-2011P - A Phase 2, Open-Label Study of AMDX-2011P as a Retinal Tracer in Participants With Cerebral Amyloid Angiopathy (CAA)
        • Table Fluorescent Retinal Contrast Agent - Parkinson's Disease - Prospective Randomized Open, Blinded Endpoint (PROBE) Study of AMDX-2011P as a Retinal Tracer in Subjects with Neurodegenerative Diseases Associated with Amyloidogenic Proteinopathy
    • Antaros Medical AB Company Overview
      • Antaros Medical AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antaros Medical AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gadoxetate DCE-MR Imaging Agent - Liver Toxicity - Product Status
        • Table Gadoxetate DCE-MR Imaging Agent - Liver Toxicity - Product Description
    • APRINOIA Therapeutics Inc Company Overview
      • APRINOIA Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table APRINOIA Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table APN-1701 - Product Status
        • Table APN-1701 - Product Description
        • Table aSyn PET Tracer - Product Status
        • Table aSyn PET Tracer - Product Description
    • Ascelia Pharma AB Company Overview
      • Ascelia Pharma AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ascelia Pharma AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orviglance - Product Status
        • Table Orviglance - Product Description
        • Table Second Generation Mangoral - Product Status
        • Table Second Generation Mangoral - Product Description
        • Table Ascelia Pharma AB - Ongoing Clinical Trials Overview
        • Table Orviglance - Study Evaluate the Influence of Hepatic Impairment on the Safety, Pharmacokinetics and Pharmacodynamics of Mangoral
    • Astellas Pharma Inc Company Overview
      • Astellas Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Astellas Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASP5354 - Product Status
        • Table ASP5354 - Product Description
    • Augurix SA Company Overview
      • Augurix SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Augurix SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table AUG-BIO 2 - Product Status
        • Table AUG-BIO 2 - Product Description
        • Table AUG-BIO 3 - Product Status
        • Table AUG-BIO 3 - Product Description
    • Auxano Biomedical, LLC. (Inactive) Company Overview
      • Auxano Biomedical, LLC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auxano Biomedical, LLC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Agents - Wounds - Product Status
        • Table Diagnostic Agents - Wounds - Product Description
    • Avelas Biosciences Inc Company Overview
      • Avelas Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avelas Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AVB-N-311 - Product Status
        • Table AVB-N-311 - Product Description
        • Table AVB-N-312 - Product Status
        • Table AVB-N-312 - Product Description
    • B-Aegis Life Sciences & Research Pvt Ltd Company Overview
      • B-Aegis Life Sciences & Research Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table B-Aegis Life Sciences & Research Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoSense - Product Status
        • Table OncoSense - Product Description
    • Bayer AG Company Overview
      • Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gadoquatrane Contrast Agent - Product Status
        • Table Gadoquatrane Contrast Agent - Product Description
        • Table Next Generation Liver MRI Contrast Agent - Product Status
        • Table Next Generation Liver MRI Contrast Agent - Product Description
    • BBS NanoTechnology Ltd Company Overview
      • BBS NanoTechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BBS NanoTechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table FCA1 - Gd Containing Paramagnetic MR T1 Contrast Agent - Product Status
        • Table FCA1 - Gd Containing Paramagnetic MR T1 Contrast Agent - Product Description
    • Beckman Research Institute Of The City Of Hope Company Overview
      • Beckman Research Institute Of The City Of Hope Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beckman Research Institute Of The City Of Hope Pipeline Products & Ongoing Clinical Trials Overview
        • Table Calreticulin ImmunoPET Probe - Product Status
        • Table Calreticulin ImmunoPET Probe - Product Description
    • Blaze Bioscience Inc Company Overview
      • Blaze Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blaze Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BLZ-100 - Product Status
        • Table BLZ-100 - Product Description
    • Bracco Imaging SpA Company Overview
      • Bracco Imaging SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bracco Imaging SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iomeron Contrast Agent - Product Status
        • Table Iomeron Contrast Agent - Product Description
        • Table Bracco Imaging SpA - Ongoing Clinical Trials Overview
        • Table Iomeron Contrast Agent - Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
    • Brown University Company Overview
      • Brown University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Brown University Pipeline Products & Ongoing Clinical Trials Overview
        • Table MR Imaging Probe - Cancer - Product Status
        • Table MR Imaging Probe - Cancer - Product Description
        • Table Nanobubble Contrast Agent - Product Status
        • Table Nanobubble Contrast Agent - Product Description
    • Case Western Reserve University Company Overview
      • Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
        • Table AI Contrast Agent - Product Status
        • Table AI Contrast Agent - Product Description
        • Table Contrast Agent - Prostate Cancer - Product Status
        • Table Contrast Agent - Prostate Cancer - Product Description
        • Table PET Imaging Agent - Product Status
        • Table PET Imaging Agent - Product Description
        • Table ZD2-Gd3N@C80 - Product Status
        • Table ZD2-Gd3N@C80 - Product Description
    • Cavatar LLC Company Overview
      • Cavatar LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cavatar LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 99mTc Based Contrast Agent - Product Status
        • Table 99mTc Based Contrast Agent - Product Description
    • Cell2in Company Overview
      • Cell2in Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cell2in Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuclear GSH Tracer - Product Status
        • Table Nuclear GSH Tracer - Product Description
    • Cellectar Biosciences Inc Company Overview
      • Cellectar Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellectar Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CLR 1502 - Product Status
        • Table CLR 1502 - Product Description
    • Centre National de la Recherche Scientifique Company Overview
      • Centre National de la Recherche Scientifique Pipeline Products & Ongoing Clinical Trials Overview
        • Table Centre National de la Recherche Scientifique Pipeline Products & Ongoing Clinical Trials Overview
        • Table Integrin Receptor Targeting Fluorescent Imaging Agent - Tumor Diagnosis - Product Status
        • Table Integrin Receptor Targeting Fluorescent Imaging Agent - Tumor Diagnosis - Product Description
    • Centurion BioPharma Corp Company Overview
      • Centurion BioPharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Centurion BioPharma Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACDx - Product Status
        • Table ACDx - Product Description
    • Chinese Academy of Sciences Company Overview
      • Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table SNAB Probe - Product Status
        • Table SNAB Probe - Product Description
    • Clarity Pharmaceuticals Ltd Company Overview
      • Clarity Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Clarity Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET Imaging Agent - Amyotrophic Lateral Sclerosis/Brain Perfusion - Product Status
        • Table PET Imaging Agent - Amyotrophic Lateral Sclerosis/Brain Perfusion - Product Description
        • Table PET Imaging Agent - Fibrosis Panel - Product Status
        • Table PET Imaging Agent - Fibrosis Panel - Product Description
    • ClearNano Inc Company Overview
      • ClearNano Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClearNano Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClearGold - Product Status
        • Table ClearGold - Product Description
        • Table ClearICG (Indocyanine Green) - Product Status
        • Table ClearICG (Indocyanine Green) - Product Description
    • Collagen Medical LLC Company Overview
      • Collagen Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Collagen Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table [68Ga]CBP8 - Product Status
        • Table [68Ga]CBP8 - Product Description
        • Table 68Ga-CM500 - Product Status
        • Table 68Ga-CM500 - Product Description
    • Cosmo Pharmaceuticals NV Company Overview
      • Cosmo Pharmaceuticals NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cosmo Pharmaceuticals NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lumeblue - Product Status
        • Table Lumeblue - Product Description
    • Curadel LLC Company Overview
      • Curadel LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Curadel LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table cRWD-ZW800-1 - Product Status
        • Table cRWD-ZW800-1 - Product Description
        • Table PanLN Forte-800 - Product Status
        • Table PanLN Forte-800 - Product Description
        • Table SLN-800 - Product Status
        • Table SLN-800 - Product Description
        • Table ZW800-1 - Product Status
        • Table ZW800-1 - Product Description
        • Table ZW800-1 - Prostate Cancer - Product Status
        • Table ZW800-1 - Prostate Cancer - Product Description
    • CytoSite BioPharma Inc Company Overview
      • CytoSite BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CytoSite BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Imaging Agent - Product Status
        • Table Diagnostic Imaging Agent - Product Description
    • Daewoong Pharmaceutical Co Ltd Company Overview
      • Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iodixanol Contrast Medium - Product Status
        • Table Iodixanol Contrast Medium - Product Description
        • Table Ioversol Contrast Medium - Product Status
        • Table Ioversol Contrast Medium - Product Description
    • Daimroc Imaging Company Overview
      • Daimroc Imaging Pipeline Products & Ongoing Clinical Trials Overview
        • Table Daimroc Imaging Pipeline Products & Ongoing Clinical Trials Overview
        • Table Silver Nanoparticle Contrast Agent - Product Status
        • Table Silver Nanoparticle Contrast Agent - Product Description
    • Diaprost AB Company Overview
      • Diaprost AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diaprost AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mab-PET-Ligand - Hu11b6 - Product Status
        • Table Mab-PET-Ligand - Hu11b6 - Product Description
    • DongKook Lifescience Co Ltd Company Overview
      • DongKook Lifescience Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DongKook Lifescience Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CT Contrast Agent I - Product Status
        • Table CT Contrast Agent I - Product Description
        • Table CT Contrast Agent II - Product Status
        • Table CT Contrast Agent II - Product Description
    • Drexel University Company Overview
      • Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultrasound Contrast Agent - Product Status
        • Table Ultrasound Contrast Agent - Product Description
    • Duke University Company Overview
      • Duke University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Duke University Pipeline Products & Ongoing Clinical Trials Overview
        • Table 18F - Radiolabeled Imaging Agent - Product Status
        • Table 18F - Radiolabeled Imaging Agent - Product Description
    • Edinburgh Molecular Imaging Ltd Company Overview
      • Edinburgh Molecular Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Edinburgh Molecular Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table EMI-137 - Product Status
        • Table EMI-137 - Product Description
        • Table EMI-200 - Product Status
        • Table EMI-200 - Product Description
        • Table EMI-300/350 - Product Status
        • Table EMI-300/350 - Product Description
        • Table EMI-400 - Product Status
        • Table EMI-400 - Product Description
        • Table EMI-500 - Product Status
        • Table EMI-500 - Product Description
        • Table EMI-600 - Product Status
        • Table EMI-600 - Product Description
        • Table EMP-100 - Product Status
        • Table EMP-100 - Product Description
        • Table EMT-100 - Product Status
        • Table EMT-100 - Product Description
        • Table EMT-101 - Product Status
        • Table EMT-101 - Product Description
    • Emory University Company Overview
      • Emory University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emory University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imaging Agent - Myocarditis - Product Status
        • Table Imaging Agent - Myocarditis - Product Description
        • Table PET Tracer - Parkinson's Disease - Product Status
        • Table PET Tracer - Parkinson's Disease - Product Description
    • Enigma Biomedical Group Inc Company Overview
      • Enigma Biomedical Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Enigma Biomedical Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CBD2115 - Product Status
        • Table CBD2115 - Product Description
    • EOS Biosciences Inc (Inactive) Company Overview
      • EOS Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table EOS Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eos-002 - Product Status
        • Table Eos-002 - Product Description
        • Table Eos-004 - Product Status
        • Table Eos-004 - Product Description
    • Expesicor Inc Company Overview
      • Expesicor Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Expesicor Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EXP-1801 - Product Status
        • Table EXP-1801 - Product Description
    • Ferric Contrast Inc Company Overview
      • Ferric Contrast Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ferric Contrast Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table K720 - Kidney Tumors - Product Status
        • Table K720 - Kidney Tumors - Product Description
        • Table L410 - Liver Tumor - Product Status
        • Table L410 - Liver Tumor - Product Description
        • Table MP89 - Multipurpose - Product Status
        • Table MP89 - Multipurpose - Product Description
    • GE HealthCare Technologies Inc Company Overview
      • GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Manganese-Based Macrocyclic Magnetic Resonance Imaging (MRI) Contrast Agent - Product Status
        • Table Manganese-Based Macrocyclic Magnetic Resonance Imaging (MRI) Contrast Agent - Product Description
        • Table Non-Lyophilised Sonazoid - Product Status
        • Table Non-Lyophilised Sonazoid - Product Description
        • Table GE HealthCare Technologies Inc - Ongoing Clinical Trials Overview
        • Table Manganese-Based Macrocyclic Magnetic Resonance Imaging (MRI) Contrast Agent - A Phase I Study to Assess the Safety Profile of Injectable Manganese Contrast Agent
    • Georgia State University Company Overview
      • Georgia State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Georgia State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protein Contrast Agent - Product Status
        • Table Protein Contrast Agent - Product Description
    • H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
      • H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluorescent Probe - Pancreatic Cancer - Product Status
        • Table Fluorescent Probe - Pancreatic Cancer - Product Description
    • Hana Pharm Co Ltd Company Overview
      • Hana Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hana Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HNP-2006 - Product Status
        • Table HNP-2006 - Product Description
    • Harvard University Company Overview
      • Harvard University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Harvard University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hyperpolarized MRI Contrast Agent - Product Status
        • Table Hyperpolarized MRI Contrast Agent - Product Description
        • Table SPECT Imaging Agent - Neurological Diseases - Product Status
        • Table SPECT Imaging Agent - Neurological Diseases - Product Description
    • Hebrew University of Jerusalem Company Overview
      • Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
        • Table CT Molecular Imaging Probe - Product Status
        • Table CT Molecular Imaging Probe - Product Description
    • Helmholtz Center Dresden Rossendorf Company Overview
      • Helmholtz Center Dresden Rossendorf Pipeline Products & Ongoing Clinical Trials Overview
        • Table Helmholtz Center Dresden Rossendorf Pipeline Products & Ongoing Clinical Trials Overview
        • Table Functionalized Silicon Nanoparticles - Product Status
        • Table Functionalized Silicon Nanoparticles - Product Description
    • Helmholtz Center Munich German Research Center for Health and Environment GmbH Company Overview
      • Helmholtz Center Munich German Research Center for Health and Environment GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Helmholtz Center Munich German Research Center for Health and Environment GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Black Nanoparticles - Product Status
        • Table Black Nanoparticles - Product Description
    • Hong Kong Baptist University Company Overview
      • Hong Kong Baptist University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hong Kong Baptist University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iridium(III) - Based Probe - Product Status
        • Table Iridium(III) - Based Probe - Product Description
    • Hong Kong Polytechnic University Company Overview
      • Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imaging-Guided Nanoparticle - Product Status
        • Table Imaging-Guided Nanoparticle - Product Description
    • Houston Methodist Research Institute Company Overview
      • Houston Methodist Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Houston Methodist Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table pH-Sensitive Dye - Product Status
        • Table pH-Sensitive Dye - Product Description
    • Hugo W. Moser Research Institute at Kennedy Krieger Inc Company Overview
      • Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table D-Glucose Contrast Agent - Product Status
        • Table D-Glucose Contrast Agent - Product Description
    • IC Targets AS Company Overview
      • IC Targets AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table IC Targets AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mangafodipir - Product Status
        • Table Mangafodipir - Product Description
        • Table IC Targets AS - Ongoing Clinical Trials Overview
        • Table Mangafodipir - Investigation of Blood-brain-barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drugresistant Epilepsy
    • ImaginAb Inc Company Overview
      • ImaginAb Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ImaginAb Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibody-Based Imaging Agent - Ovarian Cancer - Product Status
        • Table Antibody-Based Imaging Agent - Ovarian Cancer - Product Description
        • Table CD4 Imaging Agent - Product Status
        • Table CD4 Imaging Agent - Product Description
        • Table Macrophage Contrast Agent - Product Status
        • Table Macrophage Contrast Agent - Product Description
    • Imagion Biosystems Inc Company Overview
      • Imagion Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imagion Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MagSense HER2+ Breast Cancer Imaging Agent - Product Status
        • Table MagSense HER2+ Breast Cancer Imaging Agent - Product Description
        • Table Magsense Prostate Cancer Imaging Agent - Product Status
        • Table Magsense Prostate Cancer Imaging Agent - Product Description
    • iMax Diagnostic Imaging Ltd Company Overview
      • iMax Diagnostic Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table iMax Diagnostic Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gadopentetate Dimeglumine - Product Status
        • Table Gadopentetate Dimeglumine - Product Description
        • Table Macrocyclic MRI Contrast Agent - Product Status
        • Table Macrocyclic MRI Contrast Agent - Product Description
    • IMRCP Laboratory Company Overview
      • IMRCP Laboratory Pipeline Products & Ongoing Clinical Trials Overview
        • Table IMRCP Laboratory Pipeline Products & Ongoing Clinical Trials Overview
        • Table Contrast Agent - Product Status
        • Table Contrast Agent - Product Description
    • Indi Molecular Inc Company Overview
      • Indi Molecular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indi Molecular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IO Binding Agent - Product Status
        • Table IO Binding Agent - Product Description
    • Indian Council of Medical Research Company Overview
      • Indian Council of Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Council of Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imaging Agent - Alzheimer's Disease - Product Status
        • Table Imaging Agent - Alzheimer's Disease - Product Description
    • Indian Institute of Technology Delhi Company Overview
      • Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview
        • Table MRI Imaging Iron Nano-Particles - Product Status
        • Table MRI Imaging Iron Nano-Particles - Product Description
    • Inherent Targeting Inc Company Overview
      • Inherent Targeting Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inherent Targeting Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Near Infrared Nerve-Specific Fluorophore - Product Status
        • Table Near Infrared Nerve-Specific Fluorophore - Product Description
    • Inlighta Biosciences LLC Company Overview
      • Inlighta Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inlighta Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novel Contrast Agent - Lung Fibrosis - Product Status
        • Table Novel Contrast Agent - Lung Fibrosis - Product Description
        • Table ProCA32.Collagen - Product Status
        • Table ProCA32.Collagen - Product Description
        • Table ProCA32.collagen+ - Product Status
        • Table ProCA32.collagen+ - Product Description
        • Table ProCA32.CXCR4 - Product Status
        • Table ProCA32.CXCR4 - Product Description
        • Table ProCA32.EGFR - Product Status
        • Table ProCA32.EGFR - Product Description
        • Table ProCA32.GRPR - Product Status
        • Table ProCA32.GRPR - Product Description
        • Table ProCA32.HER2 - Product Status
        • Table ProCA32.HER2 - Product Description
        • Table ProCA32.Integrin - Product Status
        • Table ProCA32.Integrin - Product Description
        • Table ProCA32.PD-L1 - Product Status
        • Table ProCA32.PD-L1 - Product Description
        • Table ProCA32.PSMA - Product Status
        • Table ProCA32.PSMA - Product Description
        • Table ProCA32.vEGFR - Product Status
        • Table ProCA32.vEGFR - Product Description
    • InnoMedica Holding AG Company Overview
      • InnoMedica Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table InnoMedica Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Contrast Agent - Tumors - Product Status
        • Table Contrast Agent - Tumors - Product Description
    • Innopharmax Inc Company Overview
      • Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table D0051301 - Product Status
        • Table D0051301 - Product Description
        • Table D0131502 - Product Status
        • Table D0131502 - Product Description
    • Intuitive Surgical Inc Company Overview
      • Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IS-001 Fluorescent Imaging Agent - Product Status
        • Table IS-001 Fluorescent Imaging Agent - Product Description
    • Inventera Pharmaceutical Co Ltd Company Overview
      • Inventera Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inventera Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CT Contrast Agent - Product Status
        • Table CT Contrast Agent - Product Description
        • Table INV-001 - Product Status
        • Table INV-001 - Product Description
        • Table INV-002 - Product Status
        • Table INV-002 - Product Description
        • Table INV-003 - Product Status
        • Table INV-003 - Product Description
        • Table Nuclear Medicine Contrast Agent - Product Status
        • Table Nuclear Medicine Contrast Agent - Product Description
    • Iowa State University Company Overview
      • Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gd5Si4 MRI Contrast Agent - Product Status
        • Table Gd5Si4 MRI Contrast Agent - Product Description
        • Table Multimodal Contrast Agent - Product Status
        • Table Multimodal Contrast Agent - Product Description
    • Johns Hopkins University Company Overview
      • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table 4th Generation PSA Test - Product Status
        • Table 4th Generation PSA Test - Product Description
        • Table PET Imaging Agent - Product Status
        • Table PET Imaging Agent - Product Description
        • Table PSMA-Targeted PA Imaging Contrast Agent - Prostate Cancer - Product Status
        • Table PSMA-Targeted PA Imaging Contrast Agent - Prostate Cancer - Product Description
    • J-Pharma Co Ltd Company Overview
      • J-Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table J-Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NKO-028 - PET Diagnostic Probe - Product Status
        • Table NKO-028 - PET Diagnostic Probe - Product Description
        • Table NKO-035 - PET Diagnostic Probe - Product Status
        • Table NKO-035 - PET Diagnostic Probe - Product Description
    • King's College London Company Overview
      • King's College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table King's College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Magnetic Resonance Contrast Agent - Product Status
        • Table Magnetic Resonance Contrast Agent - Product Description
    • Knowledgepie Pvt Ltd Company Overview
      • Knowledgepie Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Knowledgepie Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gd-Based Contrast Agent - Product Status
        • Table Gd-Based Contrast Agent - Product Description
    • Korea University Guro Hospital Company Overview
      • Korea University Guro Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Korea University Guro Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table cRGD-ZW800-PEG - Product Status
        • Table cRGD-ZW800-PEG - Product Description
        • Table ZW700-1C - Product Status
        • Table ZW700-1C - Product Description
    • LadeRx LLC Company Overview
      • LadeRx LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LadeRx LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chelated Manganese-Based Contrast Agent - Product Status
        • Table Chelated Manganese-Based Contrast Agent - Product Description
    • Lantheus Holdings Inc Company Overview
      • Lantheus Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lantheus Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NAV-4694 - Product Status
        • Table NAV-4694 - Product Description
    • Lantheus Medical Imaging Inc Company Overview
      • Lantheus Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lantheus Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table LMI 1174 - Product Status
        • Table LMI 1174 - Product Description
        • Table RP782 - Product Status
        • Table RP782 - Product Description
    • Ligand Pharmaceuticals Inc Company Overview
      • Ligand Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ligand Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Captisol-Enabled (CE) Iohexol - Product Status
        • Table Captisol-Enabled (CE) Iohexol - Product Description
    • Lightpoint Medical Ltd Company Overview
      • Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HARLI - Product Status
        • Table HARLI - Product Description
    • Lipella Pharmaceuticals Inc Company Overview
      • Lipella Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lipella Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table LP - 20 - Product Status
        • Table LP - 20 - Product Description
        • Table Lipella Pharmaceuticals Inc - Ongoing Clinical Trials Overview
        • Table LP - 20 - Human Clinical Study of a Novel Bladder MRI Contrast Agent
    • Louisiana State University Company Overview
      • Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table CRC Tumor Imaging Agent - Product Status
        • Table CRC Tumor Imaging Agent - Product Description
    • Lument AB Company Overview
      • Lument AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lument AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lumentin 44 - Product Status
        • Table Lumentin 44 - Product Description
    • Macquarie University Company Overview
      • Macquarie University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Macquarie University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanoparticle Imaging Agent - Product Status
        • Table Nanoparticle Imaging Agent - Product Description
    • Mallinckrodt Institute of Radiology Company Overview
      • Mallinckrodt Institute of Radiology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mallinckrodt Institute of Radiology Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET Imaging Tracer - Product Status
        • Table PET Imaging Tracer - Product Description
    • Manzanita Pharmaceuticals Inc Company Overview
      • Manzanita Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Manzanita Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nervelight - Product Status
        • Table Nervelight - Product Description
    • Massachusetts General Hospital Company Overview
      • Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mn-PyC3A - Product Status
        • Table Mn-PyC3A - Product Description
        • Table MRI Contrast Agent - Product Status
        • Table MRI Contrast Agent - Product Description
    • Massachusetts Institute of Technology Company Overview
      • Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metal-Free MRI Contrast Agent - Product Status
        • Table Metal-Free MRI Contrast Agent - Product Description
        • Table MRI-Based Calcium Sensor - Product Status
        • Table MRI-Based Calcium Sensor - Product Description
    • Mayo Clinic Company Overview
      • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET Imaging Agent - Na[18F]PF6 - Product Status
        • Table PET Imaging Agent - Na[18F]PF6 - Product Description
    • MediBeacon Inc Company Overview
      • MediBeacon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MediBeacon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MB-102 - Product Status
        • Table MB-102 - Product Description
        • Table MB-112 - Product Status
        • Table MB-112 - Product Description
        • Table MB-202 - Product Status
        • Table MB-202 - Product Description
        • Table MB-212 - Product Status
        • Table MB-212 - Product Description
        • Table MB-301 - Product Status
        • Table MB-301 - Product Description
        • Table MB-404 - Product Status
        • Table MB-404 - Product Description
        • Table MediBeacon Inc - Ongoing Clinical Trials Overview
        • Table MB-102 - A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
        • Table MB-102 - An Open Label, Multi-Center, Safety and Pharmacokinetic Bridging Study of MB-102 (Relmapirazin) and the Use of the MediBeacon Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring in Normal and Renal Compromised Subjects for the Evaluation of Kidney Function
    • Memorial Sloan Kettering Cancer Center Company Overview
      • Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zr-89-Transferrin PET Radiotracer - Product Status
        • Table Zr-89-Transferrin PET Radiotracer - Product Description
    • Microbial Medical Inc Company Overview
      • Microbial Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microbial Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET Imaging Agent - Product Status
        • Table PET Imaging Agent - Product Description
    • Microvascular Therapeutics LLC Company Overview
      • Microvascular Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microvascular Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table MVT-100 - Product Status
        • Table MVT-100 - Product Description
        • Table MVT-101 - Product Status
        • Table MVT-101 - Product Description
        • Table MVT-102 - Product Status
        • Table MVT-102 - Product Description
        • Table MVT-103 - Product Status
        • Table MVT-103 - Product Description
        • Table MVT-104 - Product Status
        • Table MVT-104 - Product Description
        • Table MVT-105 - Product Status
        • Table MVT-105 - Product Description
    • Molecular Theranostics LLC Company Overview
      • Molecular Theranostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Molecular Theranostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluorescence Probe - Head And Neck Cancer - Product Status
        • Table Fluorescence Probe - Head And Neck Cancer - Product Description
        • Table MRI Contrast Agent - Prostate Cancer (MT218) - Product Status
        • Table MRI Contrast Agent - Prostate Cancer (MT218) - Product Description
        • Table MT216 - Product Status
        • Table MT216 - Product Description
        • Table MTP219 - Product Status
        • Table MTP219 - Product Description
        • Table Molecular Theranostics LLC - Ongoing Clinical Trials Overview
        • Table MRI Contrast Agent - Prostate Cancer (MT218) - An Open-label Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent (MT218) in Prostate Cancer Patients
    • Monash University Company Overview
      • Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultrasound Contrast Agent - Product Status
        • Table Ultrasound Contrast Agent - Product Description
    • Nanosion Co Ltd Company Overview
      • Nanosion Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanosion Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polymeric Gd Agent - Product Status
        • Table Polymeric Gd Agent - Product Description
    • Nanovista Inc Company Overview
      • Nanovista Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanovista Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotrast - CF800 - Product Status
        • Table Nanotrast - CF800 - Product Description
    • National University of Singapore Company Overview
      • National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
        • Table National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dual-Mode Contrast Agent - Product Status
        • Table Dual-Mode Contrast Agent - Product Description
    • Neuramedy Co Ltd Company Overview
      • Neuramedy Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neuramedy Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NM-501 - Product Status
        • Table NM-501 - Product Description
    • NeuroScientific Biopharmaceuticals Ltd Company Overview
      • NeuroScientific Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NeuroScientific Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 15mS.A. Diagnostic Peptide - Product Status
        • Table 15mS.A. Diagnostic Peptide - Product Description
    • Neurovation Labs Inc Company Overview
      • Neurovation Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neurovation Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NVL1 Diagnostic Tracer - Product Status
        • Table NVL1 Diagnostic Tracer - Product Description
    • Nextrast Inc Company Overview
      • Nextrast Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nextrast Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Silicone Bowel DECT Contrast Agent - Product Status
        • Table Silicone Bowel DECT Contrast Agent - Product Description
        • Table TaCZ - Product Status
        • Table TaCZ - Product Description
    • Nirvana Sciences Inc Company Overview
      • Nirvana Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nirvana Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DCE MSOT Contrast Agent - Product Status
        • Table DCE MSOT Contrast Agent - Product Description
    • Northwestern University Company Overview
      • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gd(III) Contrast Agent - Product Status
        • Table Gd(III) Contrast Agent - Product Description
        • Table Peptide Amphiphile-Conjugated MRI Contrast Agent - Product Status
        • Table Peptide Amphiphile-Conjugated MRI Contrast Agent - Product Description
    • Novara Therapeutics Ltd Company Overview
      • Novara Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novara Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Contrast Agent - Bone Diseases - Product Status
        • Table Contrast Agent - Bone Diseases - Product Description
    • NuvOx Pharma LLC Company Overview
      • NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table B7-H3-Targeted Contrast Agent - Breast Cancer - Product Status
        • Table B7-H3-Targeted Contrast Agent - Breast Cancer - Product Description
        • Table Ultrasound Contrast Agent - Atherosclerotic Plaque - Product Status
        • Table Ultrasound Contrast Agent - Atherosclerotic Plaque - Product Description
        • Table Ultrasound Contrast Agent - Endocarditis - Product Status
        • Table Ultrasound Contrast Agent - Endocarditis - Product Description
        • Table Ultrasound Contrast Agent - Pancreatic Cancer - Product Status
        • Table Ultrasound Contrast Agent - Pancreatic Cancer - Product Description
        • Table Ultrasound Contrast Agent - Uveitis - Product Status
        • Table Ultrasound Contrast Agent - Uveitis - Product Description
    • On Target Laboratories LLC Company Overview
      • On Target Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table On Target Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cytalux - Product Status
        • Table Cytalux - Product Description
        • Table On Target Laboratories LLC - Ongoing Clinical Trials Overview
        • Table Cytalux - A Pilot Study of Near-Infrared Imaging Using the Novel Imaging Agent Cytalux for Adolescent Patients With Metastatic Osteosarcoma Undergoing Pulmonary Metastasectomy
        • Table Cytalux - An Investigator Sponsored Study to Investigate the Safety and Efficacy of CYTALUX (PAFOLACIANINE) INJECTION for the Intraoperative Imaging of Prostate Cancer
        • Table Cytalux - Near-infrared Fluorescence Molecular Imaging of Adalimumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Inflammatory Bowel Disease and Rheumotoid Arthritis
    • OncoNano Medicine Inc Company Overview
      • OncoNano Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoNano Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ONM-100 - Product Status
        • Table ONM-100 - Product Description
        • Table ONM-300 - Product Status
        • Table ONM-300 - Product Description
        • Table Pegsitacianine Intraoperative Imaging Agent - Product Status
        • Table Pegsitacianine Intraoperative Imaging Agent - Product Description
        • Table OncoNano Medicine Inc - Ongoing Clinical Trials Overview
        • Table Pegsitacianine Intraoperative Imaging Agent - A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
    • Ospedaliero Ospedali Galliera Company Overview
      • Ospedaliero Ospedali Galliera Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ospedaliero Ospedali Galliera Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET Tracer - 64CuCl2 - Product Status
        • Table PET Tracer - 64CuCl2 - Product Description
    • pHLIP Inc Company Overview
      • pHLIP Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table pHLIP Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table pHLIP ICG - Product Status
        • Table pHLIP ICG - Product Description
        • Table pHLIP Inc - Ongoing Clinical Trials Overview
        • Table pHLIP ICG - Phase I/IIa Study of Pre-operative Multiparametric MRI and pHLIP ICG Intra-operative Fluorescence Imaging of Primary Breast Cancer
    • Photocure ASA Company Overview
      • Photocure ASA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Photocure ASA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hexvix - Product Status
        • Table Hexvix - Product Description
        • Table Photocure ASA - Ongoing Clinical Trials Overview
        • Table Hexvix - A Pilot, Real-world Evidence Study of Hexvix in Bladder Cancer Patients of Hainan Province of China
        • Table Hexvix - A Study to Evaluate the Use of Blue Light Cystoscopy Among Non-muscle Invasive Bladder Cancer Subjects and Outcomes in an Equal Access Setting: A Propensity Scored Matched Analysis
        • Table Hexvix - Blue Light Cystoscopy with Cysview Registry
        • Table Hexvix - Flexible Blue Light Cystoscopy with Hexaminolevulinate Provides Opportunity to Finalize Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer in the Outpatient Clinic
        • Table Hexvix - Non-inferiority, Phase IV, Open-label, Randomized Controlled Trial of Vesical Imaging- Reporting and Data System (VI-RADS) Followed by Primary Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) Versus Conventional White-light TURBT Plus Repeated-TURBT (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) Candidate for Second Look and Resection
        • Table Hexvix - Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
    • Photolitec LLC Company Overview
      • Photolitec LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Photolitec LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET-ONCO - Product Status
        • Table PET-ONCO - Product Description
    • Polarean Imaging PLC Company Overview
      • Polarean Imaging PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polarean Imaging PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table HP 3He - Product Status
        • Table HP 3He - Product Description
        • Table XENOVIEW (xenon Xe 129 hyperpolarized) - Pediatrics - Product Status
        • Table XENOVIEW (xenon Xe 129 hyperpolarized) - Pediatrics - Product Description
    • Polyaurum LLC Company Overview
      • Polyaurum LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polyaurum LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Gold Nanoparticles - Product Status
        • Table Biodegradable Gold Nanoparticles - Product Description
    • Praxis Pharmaceutical SAU Company Overview
      • Praxis Pharmaceutical SAU Pipeline Products & Ongoing Clinical Trials Overview
        • Table Praxis Pharmaceutical SAU Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microbubble Contrast Agent - Product Status
        • Table Microbubble Contrast Agent - Product Description
    • Precision Molecular Inc Company Overview
      • Precision Molecular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Precision Molecular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PMI01 - Product Status
        • Table PMI01 - Product Description
        • Table PMI03 - Product Status
        • Table PMI03 - Product Description
        • Table PMI04 - Product Status
        • Table PMI04 - Product Description
        • Table PMI05 - Product Status
        • Table PMI05 - Product Description
        • Table PMI06 - Product Status
        • Table PMI06 - Product Description
        • Table PMI06-G - Product Status
        • Table PMI06-G - Product Description
        • Table PMI07 - Product Status
        • Table PMI07 - Product Description
    • Princeton University Company Overview
      • Princeton University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Princeton University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iodine-Based Nanoparticles - Product Status
        • Table Iodine-Based Nanoparticles - Product Description
    • Quest Medical Imaging BV Company Overview
      • Quest Medical Imaging BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quest Medical Imaging BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluorescence Cancer Imaging Molecular Dye - Product Status
        • Table Fluorescence Cancer Imaging Molecular Dye - Product Description
    • QurCan Therapeutics Inc Company Overview
      • QurCan Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table QurCan Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Manganescan (T-MX) - Product Status
        • Table Manganescan (T-MX) - Product Description
    • Radiopharm Theranostics Ltd Company Overview
      • Radiopharm Theranostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Radiopharm Theranostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table RAD201 - Product Status
        • Table RAD201 - Product Description
    • Respiratorius AB Company Overview
      • Respiratorius AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Respiratorius AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table RESP-3000 - Product Status
        • Table RESP-3000 - Product Description
    • Reveal Pharmaceutical Inc Company Overview
      • Reveal Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Reveal Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RVP-001 - Product Status
        • Table RVP-001 - Product Description
    • Rice University Company Overview
      • Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET/MRI Contrast Agent - Cancer - Product Status
        • Table PET/MRI Contrast Agent - Cancer - Product Description
    • Roche Diagnostics Company Overview
      • Roche Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table NLRP3 - Product Status
        • Table NLRP3 - Product Description
    • Royal College of Surgeons Ireland Company Overview
      • Royal College of Surgeons Ireland Pipeline Products & Ongoing Clinical Trials Overview
        • Table Royal College of Surgeons Ireland Pipeline Products & Ongoing Clinical Trials Overview
        • Table NIR Fluorochrome Imaging Agent - Product Status
        • Table NIR Fluorochrome Imaging Agent - Product Description
    • SANOCHEMIA Pharmazeutika GmbH Company Overview
      • SANOCHEMIA Pharmazeutika GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table SANOCHEMIA Pharmazeutika GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vidon - Product Status
        • Table Vidon - Product Description
    • SBI Pharmaceuticals Co Ltd Company Overview
      • SBI Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table SBI Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gleolan - Product Status
        • Table Gleolan - Product Description
        • Table SBI Pharmaceuticals Co Ltd - Ongoing Clinical Trials Overview
        • Table Gleolan - A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients With Suspected Newly Diagnosed or Recurrent Epithelial Ovarian Cancer
    • Serac Ltd Company Overview
      • Serac Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Serac Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Maraciclatide - Rheumatoid Arthritis - Product Status
        • Table Maraciclatide - Rheumatoid Arthritis - Product Description
        • Table Serac Ltd - Ongoing Clinical Trials Overview
        • Table Maraciclatide - Rheumatoid Arthritis - An Observational Study Exploring the Value 99mMaracticaltide Imaging for Predicting Outcomes for Patients With Rheumatoid Arthritis Undergoing Tapering of Therapy
    • SG Endocrine Research LLC Company Overview
      • SG Endocrine Research LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SG Endocrine Research LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table MRI Imaging Agent - Product Status
        • Table MRI Imaging Agent - Product Description
    • Signablok Inc Company Overview
      • Signablok Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Signablok Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gadolinium-Based Contrast Agents - Product Status
        • Table Gadolinium-Based Contrast Agents - Product Description
    • Sirtex Medical Ltd Company Overview
      • Sirtex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sirtex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imaging Agent - Interventional Oncology - Product Status
        • Table Imaging Agent - Interventional Oncology - Product Description
    • Society of Nuclear Medicine and Molecular Imaging Company Overview
      • Society of Nuclear Medicine and Molecular Imaging Pipeline Products & Ongoing Clinical Trials Overview
        • Table Society of Nuclear Medicine and Molecular Imaging Pipeline Products & Ongoing Clinical Trials Overview
        • Table 68Ga-NOTA-GZP PET/CT - Product Status
        • Table 68Ga-NOTA-GZP PET/CT - Product Description
    • Solstice Pharmaceuticals BV Company Overview
      • Solstice Pharmaceuticals BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Solstice Pharmaceuticals BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Harmono-T - Product Status
        • Table Harmono-T - Product Description
    • Sonnest Inc Company Overview
      • Sonnest Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sonnest Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Electrast - Product Status
        • Table Electrast - Product Description
    • Sorbonne Paris Cite Company Overview
      • Sorbonne Paris Cite Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sorbonne Paris Cite Pipeline Products & Ongoing Clinical Trials Overview
        • Table Optical Imaging Agent - Liver Cancer - Product Status
        • Table Optical Imaging Agent - Liver Cancer - Product Description
    • Southern Illinois University Carbondale Company Overview
      • Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
        • Table Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolic MRI Contrast Agent - Product Status
        • Table Metabolic MRI Contrast Agent - Product Description
        • Table SPION Based Imaging Agents - Product Status
        • Table SPION Based Imaging Agents - Product Description
    • SPAGO Nanomedical AB Company Overview
      • SPAGO Nanomedical AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table SPAGO Nanomedical AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table SN132D - Product Status
        • Table SN132D - Product Description
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
      • Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Negative MR Contrast Agents - Product Status
        • Table Negative MR Contrast Agents - Product Description
        • Table Positive MR Contrast Agent - Product Status
        • Table Positive MR Contrast Agent - Product Description
    • Stanford University Company Overview
      • Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stanford University Pipeline Products & Ongoing Clinical Trials Overview
        • Table B7-H3 Affibody Ligand - Product Status
        • Table B7-H3 Affibody Ligand - Product Description
        • Table B7-H3-Targeted Contrast Agent - Breast Cancer - Product Status
        • Table B7-H3-Targeted Contrast Agent - Breast Cancer - Product Description
        • Table CCS Optical Imaging Agent - Product Status
        • Table CCS Optical Imaging Agent - Product Description
        • Table Photoacoustic Imaging - Thyroid Cancer - Product Status
        • Table Photoacoustic Imaging - Thyroid Cancer - Product Description
        • Table PSMA Imaging Agent - Prostate Cancer - Product Status
        • Table PSMA Imaging Agent - Prostate Cancer - Product Description
    • Stanford University School of Medicine Company Overview
      • Stanford University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stanford University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Two-Piece Fluorescent Probe - Product Status
        • Table Two-Piece Fluorescent Probe - Product Description
    • SunTech Medical Inc Company Overview
      • SunTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SunTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table STD-002 - Product Status
        • Table STD-002 - Product Description
        • Table STM-001 - Product Status
        • Table STM-001 - Product Description
    • SurgiMab SAS Company Overview
      • SurgiMab SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table SurgiMab SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table SGM-101 - Product Status
        • Table SGM-101 - Product Description
        • Table SGM-201 - Product Status
        • Table SGM-201 - Product Description
        • Table SGM-301 - Product Status
        • Table SGM-301 - Product Description
        • Table SurgiMab SAS - Ongoing Clinical Trials Overview
        • Table SGM-101 - A Performance Study of SGM-101, a Fluorochrome-labeled Anti-carcinoembryonic Antigen Monoclonal Antibody for Fluorescence-guided Imaging to Determine Local Extent and Resectability During Surgical Resection of Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment
        • Table SGM-101 - Multicenter, Open-label, Randomized, Controlled, Parallel Arms Clinical Study on Performance of SGM-101, a Fluorochrome-labeled Anti-CEA Monoclonal Antibody, for Delineation of Primary/Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
    • SurgVision GmbH Company Overview
      • SurgVision GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table SurgVision GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table BEVA800 - Product Status
        • Table BEVA800 - Product Description
    • Telix Pharmaceuticals Ltd Company Overview
      • Telix Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Telix Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TLX007-CDx - Product Status
        • Table TLX007-CDx - Product Description
    • The Chinese University of Hong Kong Company Overview
      • The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanoparticle Contrast Agent - Product Status
        • Table Nanoparticle Contrast Agent - Product Description
    • Theragnostic Technologies Inc Company Overview
      • Theragnostic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Theragnostic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mangradex - Product Status
        • Table Mangradex - Product Description
    • Theragnostics Ltd Company Overview
      • Theragnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Theragnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table THG-003 - Product Status
        • Table THG-003 - Product Description
        • Table THG-007 - Product Status
        • Table THG-007 - Product Description
    • Thomas Jefferson University Company Overview
      • Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultrasound Contrast Agent - Product Status
        • Table Ultrasound Contrast Agent - Product Description
    • TomoWave Laboratories Inc Company Overview
      • TomoWave Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TomoWave Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gold Nanorods Contrast Agent - Product Status
        • Table Gold Nanorods Contrast Agent - Product Description
    • Trace Biosciences Inc Company Overview
      • Trace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IT01-08 - Product Status
        • Table IT01-08 - Product Description
    • University College London Company Overview
      • University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table LipoGlucoCEST - Product Status
        • Table LipoGlucoCEST - Product Description
    • University Health Network Company Overview
      • University Health Network Pipeline Products & Ongoing Clinical Trials Overview
        • Table University Health Network Pipeline Products & Ongoing Clinical Trials Overview
        • Table Porphysome Imaging Agent - Product Status
        • Table Porphysome Imaging Agent - Product Description
    • University of Arizona Company Overview
      • University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
        • Table Molecular Scaffold - Contrast Agent - Product Status
        • Table Molecular Scaffold - Contrast Agent - Product Description
    • University of Bordeaux Company Overview
      • University of Bordeaux Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Bordeaux Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibody Based Imaging Agent - Product Status
        • Table Antibody Based Imaging Agent - Product Description
    • University of California Davis Company Overview
      • University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anti-aVß6 Diabodies - Product Status
        • Table Anti-aVß6 Diabodies - Product Description
        • Table Nitroxide-Coupled Amyloid Contrast Agents - Product Status
        • Table Nitroxide-Coupled Amyloid Contrast Agents - Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Contrast Agent - Tumor - Product Status
        • Table Injectable Contrast Agent - Tumor - Product Description
        • Table TAM-Sense Agent - Product Status
        • Table TAM-Sense Agent - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table 18F-TRX - Product Status
        • Table 18F-TRX - Product Description
        • Table PET Radiotracer - Bacterial Infections - Product Status
        • Table PET Radiotracer - Bacterial Infections - Product Description
    • University of Central Florida Company Overview
      • University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Activatable NMR/MRI Nanoprobe - Product Status
        • Table Activatable NMR/MRI Nanoprobe - Product Description
    • University of Chicago Company Overview
      • University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table AuNP-DG Imaging Agent - Product Status
        • Table AuNP-DG Imaging Agent - Product Description
        • Table MRI Imaging Agent - Ovarian Cancer - Product Status
        • Table MRI Imaging Agent - Ovarian Cancer - Product Description
    • University of Edinburgh Company Overview
      • University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imaging Tool - Lung Infection - Product Status
        • Table Imaging Tool - Lung Infection - Product Description
    • University of Gottingen Company Overview
      • University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iron paraCEST MRI Contrast Agent - Product Status
        • Table Iron paraCEST MRI Contrast Agent - Product Description
    • University of Illinois at Urbana-Champaign Company Overview
      • University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Illinois at Urbana-Champaign Pipeline Products & Ongoing Clinical Trials Overview
        • Table OCT Contrast Agent - Product Status
        • Table OCT Contrast Agent - Product Description
        • Table Plasmon-Resonant Contrast Agent - Product Status
        • Table Plasmon-Resonant Contrast Agent - Product Description
    • University of Louisville Company Overview
      • University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
        • Table Voltage-Sensitive MRI Myelographic Contrast Agents - Product Status
        • Table Voltage-Sensitive MRI Myelographic Contrast Agents - Product Description
    • University of Michigan Company Overview
      • University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table Breast Cancer Diagnosis Pill - Product Status
        • Table Breast Cancer Diagnosis Pill - Product Description
    • University of Minnesota Company Overview
      • University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET Imaging Probe - Product Status
        • Table PET Imaging Probe - Product Description
    • University of Missouri Company Overview
      • University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dual-Biomarker (GRPr/PSMA) Targeting Agent - Prostate Cancer - Product Status
        • Table Dual-Biomarker (GRPr/PSMA) Targeting Agent - Prostate Cancer - Product Description
    • University of North Carolina Company Overview
      • University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inhalable Ultrasound Contrast Agent - Product Status
        • Table Inhalable Ultrasound Contrast Agent - Product Description
    • University of Oklahoma Company Overview
      • University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview
        • Table VD-ZW800C - Product Status
        • Table VD-ZW800C - Product Description
    • University of Oxford Company Overview
      • University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable MRI Imaging Agent - Product Status
        • Table Biodegradable MRI Imaging Agent - Product Description
        • Table Next Generation X-Ray Contrast Agent - Product Status
        • Table Next Generation X-Ray Contrast Agent - Product Description
        • Table Targeted Image Contrast Agent - Product Status
        • Table Targeted Image Contrast Agent - Product Description
    • University of Pennsylvania Company Overview
      • University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gadolinium Labeled Nanocluster - Product Status
        • Table Gadolinium Labeled Nanocluster - Product Description
        • Table Hyper-CEST MR Contrast Agent - Product Status
        • Table Hyper-CEST MR Contrast Agent - Product Description
        • Table Nanoparticle X-ray Contrast Agent - Product Status
        • Table Nanoparticle X-ray Contrast Agent - Product Description
    • University of Pittsburgh Company Overview
      • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intraoperative Dual-Labeled Molecular Tracer - Product Status
        • Table Intraoperative Dual-Labeled Molecular Tracer - Product Description
        • Table Microbubble Contrast Agent - Product Status
        • Table Microbubble Contrast Agent - Product Description
    • University of Tennessee Company Overview
      • University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluorocoxib A - Product Status
        • Table Fluorocoxib A - Product Description
    • University of Texas MD Anderson Cancer Center Company Overview
      • University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table [18F]4FN - Product Status
        • Table [18F]4FN - Product Description
    • University of Texas Southwestern Medical Center Company Overview
      • University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Silica Nanoparticle Ultrasound Contrast Agent - Product Status
        • Table Silica Nanoparticle Ultrasound Contrast Agent - Product Description
    • University of Toronto Company Overview
      • University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
        • Table MnTCP Imaging Agent - Product Status
        • Table MnTCP Imaging Agent - Product Description
        • Table MnTPPS3 Imaging Agent - Product Status
        • Table MnTPPS3 Imaging Agent - Product Description
    • University of Toulouse Company Overview
      • University of Toulouse Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Toulouse Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multimodal Imaging Contrast Agent - Product Status
        • Table Multimodal Imaging Contrast Agent - Product Description
    • University of Tsukuba Company Overview
      • University of Tsukuba Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Tsukuba Pipeline Products & Ongoing Clinical Trials Overview
        • Table GPU-327 - Product Status
        • Table GPU-327 - Product Description
    • University of Virginia Company Overview
      • University of Virginia Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Virginia Pipeline Products & Ongoing Clinical Trials Overview
        • Table PET Tracer - Pancreatic Cancer - Product Status
        • Table PET Tracer - Pancreatic Cancer - Product Description
    • University of Washington Company Overview
      • University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thy-1 Microbubble - Product Status
        • Table Thy-1 Microbubble - Product Description
    • University of Wisconsin Madison Company Overview
      • University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
        • Table 68Ga-FAPI-46 - Product Status
        • Table 68Ga-FAPI-46 - Product Description
    • VA Ann Arbor Healthcare System Company Overview
      • VA Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
        • Table VA Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cholesterol-Analog Contrast Agent - Product Status
        • Table Cholesterol-Analog Contrast Agent - Product Description
    • Vanderbilt University Company Overview
      • Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cox-2 Imaging Agent - Head/Neck And Colon Cancer - Product Status
        • Table Cox-2 Imaging Agent - Head/Neck And Colon Cancer - Product Description
        • Table Cyclen Based Imaging Agent - Product Status
        • Table Cyclen Based Imaging Agent - Product Description
        • Table Hypoxia Sensitive Imaging Agent - Product Status
        • Table Hypoxia Sensitive Imaging Agent - Product Description
        • Table Peptide Targeted Imaging Agent - Product Status
        • Table Peptide Targeted Imaging Agent - Product Description
        • Table Peripheral Benzodiazepine Receptor Ligand Imaging Agent - Product Status
        • Table Peripheral Benzodiazepine Receptor Ligand Imaging Agent - Product Description
        • Table TPSO Ligand Imaging Agent - Product Status
        • Table TPSO Ligand Imaging Agent - Product Description
    • Vascular BioSciences Company Overview
      • Vascular BioSciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular BioSciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imaging Agent - COVID-19 - Product Status
        • Table Imaging Agent - COVID-19 - Product Description
        • Table Imaging Agent - Pulmonary Hypertension - Product Status
        • Table Imaging Agent - Pulmonary Hypertension - Product Description
        • Table Imaging Agent - Sepsis - Product Status
        • Table Imaging Agent - Sepsis - Product Description
    • Vect-Horus SAS Company Overview
      • Vect-Horus SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vect-Horus SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imaging Agent - Brain Tumors - Product Status
        • Table Imaging Agent - Brain Tumors - Product Description
        • Table Imaging Agent - Other Tumors - Product Status
        • Table Imaging Agent - Other Tumors - Product Description
        • Table Imaging Agent - Pancreatic Cancer - Product Status
        • Table Imaging Agent - Pancreatic Cancer - Product Description
    • Vergent Bioscience Inc Company Overview
      • Vergent Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vergent Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VGT-309 - Product Status
        • Table VGT-309 - Product Description
        • Table Vergent Bioscience Inc - Ongoing Clinical Trials Overview
        • Table VGT-309 - A Phase 2, Multi-center, Open-label Study to Evaluate the Safety and Efficacy of VGT-309, a Tumor-Targeted, Activatable Fluorescent Imaging Agent, in Subjects Undergoing Surgery for Cancer in the Lung
        • Table VGT-309 - A Phase II, Open-label Study to Evaluate the Safety, Efficacy, Dosing, and Timing of VGT-309, a Tumor-Targeted, Activatable Fluorescent Imaging Agent for the Intraoperative Identification of Lung Cancer
        • Table VGT-309 - Pilot Open Label Study to Determine the Safety and Efficacy of Fluorescent Probe, VGT-309, to Identify Cancerous Colorectal Lesions During White-Light and Fluorescence Augmented Colonoscopy
    • Verity Pharmaceuticals Inc Company Overview
      • Verity Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Verity Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Agent - Product Status
        • Table Diagnostic Agent - Product Description
    • Videns og Forskningscenter for Alternativ Behandling Company Overview
      • Videns og Forskningscenter for Alternativ Behandling Pipeline Products & Ongoing Clinical Trials Overview
        • Table Videns og Forskningscenter for Alternativ Behandling Pipeline Products & Ongoing Clinical Trials Overview
        • Table VLS-1 - Product Status
        • Table VLS-1 - Product Description
        • Table VLS-2 - Product Status
        • Table VLS-2 - Product Description
        • Table VLS-4 - Product Status
        • Table VLS-4 - Product Description
    • Voyageur Pharmaceuticals Ltd Company Overview
      • Voyageur Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Voyageur Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iohexol - Product Status
        • Table Iohexol - Product Description
        • Table Iopamidol - Product Status
        • Table Iopamidol - Product Description
        • Table SmoothX - Product Status
        • Table SmoothX - Product Description
        • Table VY-101 - Product Status
        • Table VY-101 - Product Description
        • Table VY-102 - Product Status
        • Table VY-102 - Product Description
        • Table VY-103 - Product Status
        • Table VY-103 - Product Description
    • Vyripharm Biopharmaceuticals Company Overview
      • Vyripharm Biopharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vyripharm Biopharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
        • Table VYR-206 - Product Status
        • Table VYR-206 - Product Description
    • Washington University in St Louis Company Overview
      • Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
        • Table Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioconjugate-Optical Imaging Agent - Product Status
        • Table Bioconjugate-Optical Imaging Agent - Product Description
        • Table Colloidal Iron Oxide Contrast Agent - Product Status
        • Table Colloidal Iron Oxide Contrast Agent - Product Description
    • Wayne State University Company Overview
      • Wayne State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wayne State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation MRI Contrast Imaging Agent - Product Status
        • Table Next Generation MRI Contrast Imaging Agent - Product Description
    • Weizmann Institute of Science Company Overview
      • Weizmann Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Weizmann Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novel MRI Contrast Agent - Product Status
        • Table Novel MRI Contrast Agent - Product Description
    • Xemed LLC Company Overview
      • Xemed LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xemed LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table MagniXene - Product Status
        • Table MagniXene - Product Description
        • Table Xemed LLC - Ongoing Clinical Trials Overview
        • Table MagniXene - A Prospective Study of Hyperpolarized 129 Xe MRI in in a Pediatric Population with Bronchopulmonary Dysplasia
        • Table MagniXene - Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI
        • Table MagniXene - Hyperpolarized 129 Xenon MRI in a Pediatric Population with Lung Transplant
        • Table MagniXene - New Strategies for Pulmonary Assessment in Spinal and Chest Wall Deformity
        • Table MagniXene - Pilot Study of Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation
    • XN Biotechnologies LLC Company Overview
      • XN Biotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table XN Biotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table RadioCF-PET - Product Status
        • Table RadioCF-PET - Product Description
    • Yale University Company Overview
      • Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table PD-L1 BBB PET Imaging Agent - Product Status
        • Table PD-L1 BBB PET Imaging Agent - Product Description
    • Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd Company Overview
      • Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Minims Fluorescein Sodium - Product Status
        • Table Minims Fluorescein Sodium - Product Description
  • Contrast Agents- Recent Developments
    • Aug 15, 2024: New Method Could Lower Radiotherapy Doses For Some Cancer Patients
    • Aug 15, 2024: Study Confirms Frequency of Undetected Responsiveness in Severe Brain Injury
    • Aug 08, 2024: Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024
    • Aug 08, 2024: Advanced MRI Scans Help Identify One in Three Concussion Patients with `Hidden Disease'
    • Aug 07, 2024: Consun Pharmaceutical : Drug Registration Approval for Iopromide Injection
    • Aug 01, 2024: Polarean Imaging Announces FDA submission to expand minimum age for XENOVIEW
    • Jul 31, 2024: New Xenon MRI System trade-in agreement entered with the University of Kansas Medical Center
    • Jul 25, 2024: Novel PET Imaging Tool Identifies Early Signs of Inflammatory Bowel Disease and Predicts Response to Treatment
    • Jul 25, 2024: Immunis Joins Hands With Springbok Analytics on MRI-based AI Muscle Analysis Technology
    • Jul 24, 2024: Sharing Brain Images Can Foster New Neuroscience Discoveries
    • Jul 23, 2024: FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
    • Jul 15, 2024: Vanderbilt Scientists Develop New Tool That Could Lead to Noninvasive "liquid biopsies"
    • Jul 11, 2024: Hyperfine to Announce Second Quarter 2024 Financial Results on August 8, 2024
    • Jul 09, 2024: AI-Powered Antenna Revolutionizes Bone Fracture Diagnosis
    • Jul 08, 2024: Domestic Launch of the In Vitro Diagnostic Pharmaceutical "Shionogi MIC Dry Plate Cefiderocol"
    • Jun 21, 2024: NX Development Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan
    • Jun 18, 2024: Cosmo's oral diagnostic drug Lumeblue receives approval of New Drug Application in China
    • Jun 18, 2024: China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-Release Tablets Approved for Marketing in China
    • Jun 17, 2024: Ezra Launches Partnership with AMRIC Health to Enable Whole-Body MRI Screenings in New York Clinics
    • Jun 12, 2024: Sino Biopharmaceutical : Voluntary Announcement Approval for Marketing of Gadoteridol Injection
    • Jun 12, 2024: SNMMI 2024 Annual Meeting Spotlights Cutting-Edge Research, Spurring Innovation Across the Field
    • Jun 03, 2024: Hyperfine to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
    • May 27, 2024: Telix seeks prostate cancer imaging kit approval from FDA
    • May 23, 2024: IXICO Announces Alzheimer's Disease (AD) Trial Contract Win
    • May 22, 2024: HKU Engineering Team Enhances Stereotactic Neurosurgery Precision Using MRIGuided Multi-Stage Robotic Positioner
    • May 14, 2024: Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
    • May 08, 2024: Polarean's Xenon MRI to be Featured at Upcoming ATS 2024 Conference
    • May 07, 2024: Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
    • May 07, 2024: University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
    • May 06, 2024: JNM Supplement Highlights Nuclear Medicine Innovation in China
    • May 02, 2024: Ascelia Pharma Successfully Meets Primary Endpoint With Strong Headline Results in Orviglance Phase 3 Study
    • Apr 30, 2024: Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy
    • Apr 28, 2024: CYTALUX Real-World Experience Presented at the American Association for Thoracic Surgery 104th Annual Meeting
    • Apr 17, 2024: Korean, US Researchers Develop New Dual Fluorescence Imaging Technique for Precision Lung Cancer Surgery
    • Apr 16, 2024: Clinical Trial Looks to Improve Treatment of Early-Stage Breast Cancer
    • Apr 12, 2024: Hengrui Pharmaceutical's Three Innovative Drugs HRS-9231 Injection, SHR-4597 Inhalation and SHR-2173 Injection Were Approved for Clinical Trials
    • Apr 08, 2024: European Association of Urology (EAU) 2024 Congress Features New Data on Modern Technology Use in Bladder Cancer Care
    • Apr 01, 2024: UC San Diego Receives $6.7M to Develop Whole-Body Inflammation Imaging
    • Mar 28, 2024: New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
    • Mar 25, 2024: Sino Biopharmaceutical: Voluntary Announcement Approval for Marketing of Iopromide Injection
    • Mar 20, 2024: MD Anderson Research Highlights for March 20, 2024
    • Mar 19, 2024: MINDSET Integrated And US Radiology Specialists Announce Strategic Agreement On Brain Injury Assessment
    • Mar 14, 2024: Subtle Medical Supports R01 Grant for AI-Powered Pediatric Imaging Secured with Researchers at Boston Children's Hospital and Massachusetts General Hospital
    • Mar 05, 2024: NX Development is Granted Orphan-Drug Designation Status by US FDA for Gleolan in Ovarian and Related Cancers
    • Feb 29, 2024: Medtronic Files ITC Action Against Axonics to Stop Unauthorized Use of Medtronic Innovations
    • Feb 28, 2024: Collaborative Development of AI Technology to Precisely Extract Areas Suspected of Glioma from MRI Images
    • Feb 08, 2024: New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
    • Feb 07, 2024: Isotopia USA is thrilled to announce its new partnership with E Solutions and Comfort Systems USA to build out its North American headquarters and US GMP manufacturing center
    • Jan 29, 2024: Photocure Partner Asieris Presented Clinical Trial and Real-World Data on Hexvix in China at ASCO GU 2024
    • Jan 29, 2024: Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU
    • Jan 28, 2024: Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery
    • Jan 19, 2024: Innovative Imaging solution offers potential breakthrough in endometriosis detection
    • Jan 12, 2024: Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results
    • Jan 03, 2024: Case Western Reserve Researchers Land $1.1m National Science Foundation Grant to Advance Safer, Faster and Less Expensive Medical-Imaging Technology
    • Dec 19, 2023: Study Discovers Novel Biomarker for Vascular Aging and Neurodegeneration
    • Dec 18, 2023: Heart Vest Could Help Predict Sudden Cardiac Death Risk
    • Dec 15, 2023: Spago Nanomedical Reports Positive Top Line Data from Clinical Phase IIa Study SPAGOPIX-02 In Patients with Endometriosis
    • Dec 15, 2023: Photocure Partner Asieris To Present Unpublished Clinical Trial and Real-World Data on Hexvix in China at ASCO GU 2024
    • Dec 13, 2023: Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense HER2 Imaging Agent
    • Dec 13, 2023: Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries
    • Dec 12, 2023: Bracco wins EU approval for MRI contrast agent
    • Dec 11, 2023: Guerbet announces marketing authorisation approval of Elucirem (Gadopiclenol) in the European Union
    • Dec 01, 2023: SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy
    • Nov 27, 2023: Guerbet to Spotlight Diagnostic Solutions at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting
    • Nov 22, 2023: Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation
    • Nov 22, 2023: Novel MRI Reveals Brain Changes in Long-COVID Patients
    • Nov 20, 2023: Biggest Prostate Cancer Screening Trial in Decades to Start in UK
    • Nov 14, 2023: Amydis Receives $3.4 million NIH Commercialization Readiness Pilot Grant Award to Map Heterogeneity of Alzheimer's Diseases in Human Clinical Trial Using Novel Retinal Tracer
    • Nov 06, 2023: CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
    • Nov 02, 2023: Guerbet to Spotlight Diagnostic and Interventional Solutions at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting
    • Nov 02, 2023: Amydis Launches Phase 2 Glaucoma Clinical Program Using Novel Retinal Tracer to Detect Amyloid Beta
    • Oct 25, 2023: Ligand To Report Third Quarter 2023 Financial Results On November 8
    • Oct 19, 2023: Hyperfine to Announce Third Quarter Financial Results on November 9, 2023
    • Oct 16, 2023: Researchers Develop Innovative Technique for Distinguishing Tumor from Normal Tissue
    • Oct 12, 2023: Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress
    • Oct 12, 2023: Vueway (Gadopiclenol) Receives Positive CHMP Opinion
    • Oct 09, 2023: Imagion Presents Ovarian Cancer Data at AACR Conference
    • Oct 09, 2023: France Concludes There Is Insignificant Cost Difference Between White Light and Blue Light Cystoscopy Use When Applying Ccafu Guidelines
    • Oct 07, 2023: Photocure Partner Asieris to Present First Results for Its Hexvix Phase III Clinical Trial in China at the SIU 2023 Annual Meeting
    • Oct 04, 2023: Northwestern's First Woman Director of Bands to Retire
    • Oct 02, 2023: Human Disease Simulator Lets Scientists Choose Their Own Adventure
    • Sep 21, 2023: Bracco Imaging Announces Global Agreement With Subtle Medical
    • Sep 15, 2023: New Test Helps Drug Discoverers Identify Future Cancer Treatments
    • Sep 14, 2023: Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media
    • Sep 13, 2023: Multi-Institutional Center for the Mechanical Control of Chemistry Awarded $20M CCI Grant
    • Sep 11, 2023: Phase 2 Data Demonstrate Potential of Vergent Biosciences' Tumor-Targeted Fluorescent Imaging Agent to Improve Success of Lung Cancer Surgeries
    • Sep 08, 2023: Polarean Imaging : Partnership with VIDA To Streamline Adoption of Advanced MRI of the Lungs
    • Sep 08, 2023: Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs
    • Sep 07, 2023: Simple Contrast Ultrasound Scan Resolves Indeterminate MR and CT
    • Sep 06, 2023: Vanderbilt Researchers Develop Innovative Plasmonic Nanotweezer to More Rapidly Trap Potentially Cancerous Nanosized Particles
    • Sep 06, 2023: Isotopia Issues a Call to Action to the Radionuclide Therapy Industry
    • Aug 30, 2023: Andrew Papachristos Named New Director of Institute for Policy Research
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings